Legend Biotech Corp ADR (NASDAQ: LEGN) is -33.46% lower on its value in year-to-date trading and has touched a low of $38.60 and a high of $70.13 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LEGN stock was last observed hovering at around $40.03 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $40.04, the stock is -8.08% and -15.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.54 million and changing 0.02% at the moment leaves the stock -22.28% off its SMA200. LEGN registered -37.64% loss for a year compared to 6-month gain of -6.82%. The firm has a 50-day simple moving average (SMA 50) of $47.5487 and a 200-day simple moving average (SMA200) of $51.598576.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -19.92% loss in the last 1 month and extending the period to 3 months gives it a -29.85%, and is -8.19% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.62% over the week and 5.26% over the month.
Legend Biotech Corp ADR (LEGN) has around 1826 employees, a market worth around $7.33B and $455.99M in sales. Profit margin for the company is -62.50%. Distance from 52-week low is 3.73% and -42.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-19.07%).
with sales reaching $143.87M over the same period.The EPS is expected to grow by 39.33% this year, but quarterly earnings will post 105.90% year-over-year. Quarterly sales are estimated to grow 49.80% in year-over-year returns.
Legend Biotech Corp ADR (LEGN) Top Institutional Holders
The shares outstanding are 181.91M, and float is at 181.45M with Short Float at 6.59%.
The top institutional shareholder in the company is FMR LLC with over 17.62 million shares valued at $780.46 million. The investor’s holdings represent 9.6819% of the LEGN Shares outstanding. As of 2024-06-30, the second largest holder is PRICE T ROWE ASSOCIATES INC /MD/ with 11.49 million shares valued at $508.86 million to account for 6.3126 of the shares outstanding. The other top investors are RA CAPITAL MANAGEMENT, L.P. which holds 7.51 million shares representing 4.1246% and valued at over $332.48 million, while HHLR ADVISORS, LTD. holds 3.6463 of the shares totaling 6.64 million with a market value of $293.93 million.
Legend Biotech Corp ADR (LEGN) Insider Activity
#####
Still, SEC filings show that on Sep 20 ’24, Yau Wai Man Philip (Director) Proposed Sale 1,946 shares at an average price of $51.04 for $99324.0. The insider now directly holds shares of Legend Biotech Corp ADR (LEGN).
